Skip to main content Skip to main navigation
Government logo | to homepage of Loket Gentherapie National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • EN
  • NL
  • Home
  • Gene Therapy Office
    • History
    • Overview of assessment bodies
    • Assessment procedures
    • Tips for the applicant
  • Preliminary consult
    • Assessment frameworks
    • Preparation by the investigator
    • Organisation
  • Application form
    • Part A: Biosafety aspects
    • Part B: Patient-related aspects
  • Ongoing study
    • What to do in the event of changes to the research
    • What to do in the event of adverse events and unexpected circumstances
    • Periodic reports and notifications
  • Links
  • FAQ
  • Home
  • News

News


Search

Fill in your search phrase.

Topics

Selecting an option will change the focus to the start of the list.

Publication date

Selecting an option will change the focus to the start of the list.
  • (-) July 2020 (1)
  • March 2020 (1)
  • July 2019 (1)

Requirement applications for deliberate release of gmo’s application for COVID-19 clinical trials COVID-19 is temporarily suspended

On July 17 2020 the European Commission published a regulation that a day later, on 2020, July 18 took effect .

07/21/2020 - 14:16

Service

  • Contact
  • RIVM.nl
  • Archive

About this site

  • Sitemap
  • Cookies
  • Toegankelijkheid
  • Proclaimer
  • Responsible disclosure
  • Privacy